Nigeria Explores Innovative Tech to Boost Local Drug Production

Nigeria's pharmaceutical sector heavily relies on imports, with 75% of pharmaceutical products being brought in from countries like India, the United Kingdom, and China. This import dependency exposes the nation to supply chain disruptions, foreign exchange volatility, and drug shortages, impacting public health and industrial development.

To address this, Nigeria is focusing on modernizing its pharmaceutical sector through innovative technology and legal and financial incentives. The National Agency for Food and Drug Administration and Control (NAFDAC) plays a key role in regulating pharmaceutical products in Nigeria, ensuring compliance with good manufacturing practices and enforcing sanctions against substandard or counterfeit drugs.